Key takeaways:
Mounjaro is an FDA-approved medication for treating Type 2 diabetes.
Some people report headaches with Mounjaro. This may be related to side effects of Mounjaro such as low blood sugar and dehydration.
Drinking fluids throughout the day, avoiding low blood sugars, and limiting alcohol intake can help prevent a Mounjaro headache.
Mounjaro (tirzepatide) is an injectable medication used to treat Type 2 diabetes. For some people with Type 2 diabetes, taking Mounjaro can lower hemoglobin A1C, the long-term measure of blood sugar control.
While Mounjaro can be an excellent tool to help manage blood sugar levels, taking Mounjaro does carry a risk of side effects. The most common side effects of Mounjaro are nausea, diarrhea, decreased appetite, and vomiting.
Some people taking Mounjaro also experience headaches. But are headaches a side effect of Mounjaro use? Let’s review the evidence behind Mounjaro and headaches.
To understand possible side effects of a medication, it’s helpful to know how it works. Mounjaro is similar to other injectable medications for diabetes, such as Ozempic. But it works a little bit differently.
Mounjaro is the first medication approved in a new class of drugs called dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists (called a dual GIP receptor / GLP-1 receptor agonists for short).
This means that Mounjaro acts like both of the natural GLP-1 and GIP hormones in your body. GLP-1 and GIP are gut hormones that help balance blood sugar levels and manage appetite.
Mounjaro works by:
Increasing insulin production
Making the body more sensitive to insulin
Causing you to feel less hungry
Helping you feel full faster
There’s no evidence that Mounjaro directly causes headaches.
But some common side effects of Mounjaro can lead to headaches. And Mounjaro is a relatively new medication. This means researchers are still learning about its long-term effects.
Let’s go through how you might develop a headache while taking Mounjaro.
Mounjaro lowers blood sugar levels. Severely low blood sugar levels aren’t common on Mounjaro. But it can happen if you’re also taking other medications that lower your blood sugar, such as insulin or sulfonylureas.
If your blood sugar drops too low (this is called hypoglycemia), you can start to feel sick. Symptoms of hypoglycemia include feeling:
Warm
Dizzy
Weak
Hungry
Some people also develop a headache if they become hypoglycemic.
Mounjaro decreases your appetite and makes you feel full longer. This causes you to eat and drink less. Plus, Mounjaro slows down how fast food empties out of your stomach. This can lead to nausea and vomiting.
As a result of these side effects, people taking Mounjaro can become dehydrated. And with dehydration, there’s the risk of getting a headache. Dehydration headaches have been described as feeling like someone is squeezing the top of your head. Dehydration can also trigger other types of headaches like migraines or tension headaches.
There’s no direct interaction between Mounjaro and alcohol. But drinking alcohol can worsen the side effect of Mounjaro. That’s why it’s best to avoid combining Mounjaro and alcohol if you can.
Alcohol and Mounjaro together can increase the risk of becoming dehydrated or hypoglycemic — both of which can cause a headache.
Here are two ways this happens:
Alcohol makes you pee more. And it also directly irritates your stomach lining. This can cause nausea and vomiting. So, drinking alcohol while taking Mounjaro may make you dehydrated and trigger a headache.
Alcohol can also lower your blood sugar. This means there is a risk of hypoglycemia if you’re drinking alcohol while taking Mounjaro. Symptoms of hypoglycemia may include dizziness, sweating, and headache.
Some of the common side effects of Mounjaro can lead to headaches. But a few simple measures can help prevent and relieve a Mounjaro headache.
Drinking enough fluids is important to avoid dehydration and dehydration-related headaches. You can help yourself drink more water by carrying a refillable water bottle with you.
Some people find it helpful to set reminders on their phone to encourage them to drink throughout the day.
Up to 20% of people taking Mounjaro experience nausea as a side effect.
Eating smaller meals and using over-the-counter (OTC) medications can help. But be sure to talk to your healthcare professional if you experience nausea while taking Mounjaro. And seek out emergency care if you also have abdominal pain. This can be a sign of a more serious side effect, like gallbladder problems.
When you start Mounjaro, your healthcare professional may advise you to monitor your blood sugar more often. This is especially true if you’re taking other medications that can lower your blood sugar.
Recognizing low blood sugar and treating it quickly with a fast-acting sugar source is important. Untreated hypoglycemia can be life-threatening.
Let your healthcare professional know if your blood sugar levels are dropping too low. Your other medications may need to be adjusted to avoid hypoglycemia.
Acetaminophen and ibuprofen are common OTC medications for headache relief. But talk with your healthcare professional before taking ibuprofen if you have chronic kidney disease or problems with gastric ulcers.
Mounaro is an FDA-approved treatment for Type 2 diabetes. Some people report headaches as a side effect of Mounjaro. While Mounjaro doesn’t seem to cause headaches directly, the medication can lower your blood sugar or lead to dehydration — both of which can trigger headaches. You can reduce your risk of getting a headache while taking Mounjaro by monitoring your blood sugar, drinking plenty of fluids, and avoiding alcohol. Talk to your healthcare professional if you have side effects while taking Mounjaro.
American Diabetes Association. (n.d.). Alcohol and diabetes.
Arca, K. N., et al. (2021). Dehydration and headache. Current Pain and Headache Reports.
Farzam, K., et al. (2023). Tirzepatide. StatPearls.
Karrar, H. R., et al. (2023). Tirzepatide-induced gastrointestinal manifestations: A systematic review and meta-analysis. Cureus.
Matthew, P., et al. (2022). Hypoglycemia. StatPearls.
Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): A double-blind, randomised, phase 3 trial. The Lancet.
Seino, Y., et al. (2010). GIP and GLP‐1, the two incretin hormones: Similarities and differences. Journal of Diabetes Investigation.
Swift, R., et al. (1998). Alcohol hangover. Alcohol Health and Research World.
U.S. Food and Drug Administration. (2023). Drug trials snapshots: Mounjaro.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.